Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3)

NCT03244644 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

320

Enrollment

INDUSTRY

Sponsor class

Conditions

Clostridium Difficile Infection (CDI)

Interventions

DRUG: RBX2660
DRUG: Placebo
DRUG: Open label RBX2660 (only for confirmed CDI recurrence)

Sponsor

Rebiotix Inc.